Altered APP Carboxyl-Terminal Processing Under Ferrous Iron Treatment in PC12 Cells.
10.4196/kjpp.2013.17.3.189
- Author:
Chi Hyun KIM
1
;
Yeong Min YOO
Author Information
1. Department of Biomedical Engineering, College of Health Science, Yonsei University, Wonju 220-710, Korea. yooym@yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
ADAM10;
APP-alpha/beta-CTF;
APP processing;
BACE1;
Ferrous iron;
p-ERK
- MeSH:
Alzheimer Disease;
Amyloid;
Animals;
Brain;
Cell Survival;
Indoles;
Ions;
Iron;
PC12 Cells;
RNA, Messenger
- From:The Korean Journal of Physiology and Pharmacology
2013;17(3):189-195
- CountryRepublic of Korea
- Language:English
-
Abstract:
Amyloid-beta peptide (Abeta), generated by proteolytic cleavage of the amyloid precursor protein (APP), plays a pivotal role in the pathogenesis of Alzheimer's disease (AD). The key step in the generation of Abeta is cleavage of APP by beta-site APP-cleaving enzyme 1 (BACE1). Levels of BACE1 are increased in vulnerable regions of the AD brain, but the underlying mechanism is unknown. In the present study, we reported the effects of ferrous ions at subtoxic concentrations on the mRNA levels of BACE1 and a-disintegrin-and-metalloproteinase 10 (ADAM10) in PC12 cells and the cell responses to ferrous ions. The cell survival in PC12 cells significantly decreased with 0 to 0.3 mM FeCl2, with 0.6 mM FeCl2 treatment resulting in significant reductions by about 75%. 4,6-diamidino-2-phenylindole (DAPI) staining showed that the nuclei appeared fragmented in 0.2 and 0.3 mM FeCl2. APP-alpha-carboxyl terminal fragment (APP-alpha-CTF) associations with ADAM10 and APP-beta-CTF with BACE1 were increased. Levels of ADAM10 and BACE1 mRNA increased in response to the concentrations of 0.25 mM, respectively. In addition, p-ERK and p-Bad (S112, S155) expressions were increased, suggesting that APP-CTF formation is related to ADAM10/BACE1 expression. Levels of Bcl-2 protein were increased, but significant changes were not observed in the expression of Bax. These data suggest that ion-induced enhanced expression of AMDA10/BACE1 could be one of the causes for APP-alpha/beta-CTF activation.
